# A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

> **NCT03357731** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 49 (actual)

## Conditions studied

- Heart Failure
- Cardiac Failure
- Reduced Ventricular Ejection Fraction

## Interventions

- **DRUG:** HNO Donor
- **DRUG:** Nitroglycerin (NTG)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03357731
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-30
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03357731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03357731, "A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03357731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*